Patent · US Expired

Immunoglobulin superantigen binding to gp 120 from HIV

US5691135A · kind A · utility

10Cited by
0References
3Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 14, 1994
Grant dateNov 25, 1997
Priority date
Expiry dateSep 14, 2014

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S435/974
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

VH3 and VH4 type immunoglobulins display superantigen-type binding affinity for the HIV gp120 envelope glycoprotein. VH3 and VH4 type antibody molecules, including IgG and IgM, are shown to suppress HIV infection in vivo and in vitro. Determining the level of such antibody molecules is correlated to the advancement of HIV disease state.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.